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Objective: To discuss the utility of Sit-to-Stand Test (STST) compared to the 6min
walking test (6MWT) for the evaluation of functional status in patients with chronic
obstructive pulmonary disease (COPD).
Material-Method: Subjects: Fifty-three patients with stable COPD (mean forced
expiratory volume in 1 s (FEV1) 4679% predicted, mean age 71712year) and 15 healthy
individuals (mean FEV1 101713% predicted and mean age 6378) were included.
Interventions: Functional performance was evaluated by STST and 6MWT. During the
tests, severity of dyspnea (by Modiﬁed Borg Scale), heart rate, pulsed oxygen saturation
(SpO2, by Modiﬁed Borg Scale) (by pulse oxymeter), blood pressure were measured. The
pulmonary function (by spirometry), quadriceps femoris muscle strength (by manual
muscle test) and quality of life (by Nottingham Health Proﬁle Survey) were evaluated.
Results: The STST and 6MWT results were lower in COPD group than the healthy
group (Po0.05). During the 6MWT the rise in the heart rate, systolic blood pressure
and the decrease in SpO2 were statistically signiﬁcant according to STST in COPD
groups (Po0.05). The STST and 6MWT were strongly correlated with each other in
both groups (Po0.05). Similarly, they were correlated with age, quality of life,
peripheral muscle strength and dyspnea severity in COPD groups (Po0.05).
Conclusion: Similar to 6MWT, STST is also able to determine the functional state
correctly. Additionally, it produces less hemodynamical stress compared to the 6MWT. In
conclusion, STST can be used as an alternative of the 6MWT in patients with COPD.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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pressure; SpO2, pulsed oxygen saturation.
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The Sit-to-Stand Test in patients with COPD 287Introduction healthy individuals who had normal respiratoryIn patients with chronic obstructive pulmonary
disease (COPD), pulmonary problems and periph-
eral muscle weakness lead to sedentary life which
reduces functional status.1 So evaluating the
functional status is very important for prescribing
correct medical therapy and pulmonary rehabilita-
tion programs in these patients.2–4
As a submaximal exercise test, the 6min walking
test (6MWT) is a good predictor of functional status
for patients with chronic respiratory disease.1,2,5
The 6MWT is easy to administer, well tolerated and
more reﬂective of activities of daily life than the
other walk tests and cardiopulmonary exercise
tests.6
Standing up from sitting position is a very
common and essential activity which enables other
vital activities possible, such as walking in daily
life. The ability to stand up from a chair is an
important component to maintaining independence
for elderly people and for individuals with disabil-
ities.7,8 For this reason, Sit-to-Stand Test (STST) has
been accepted as an indicator of functional status
for elderly people.9
Therefore, we concluded that, similar to the
6MWT, STST can be used to determine the func-
tional status in patients with COPD. So the aim of
the present study is to evaluate the functional
status by the STST and the 6MWT in patients with
COPD, and to compare the results of both tests
according to some outcome parameters of the
patients (pulmonary function, severity of dyspnea
and hemodynamical stress and quality of life and
peripheral muscle strength) in order to investigate
the utility of STST for patients with COPD.Material and methods
Subjects
Fifty-three consecutive respiratory patients, 33
male and 20 female (the mean forced expiratory
volume in 1 s (FEV1) 4679% predicted, mean age
71712 years), admitted to the out-patient clinic
of chest diseases (University of Dokuz Eylul,
Department of Chest Disease). All these patients
presented clinical histories consistent with
moderate-to-severe COPD by the GOLD-2003.10 All
patients were in a clinically stable state for a
minimum of 2 weeks and had no recent infectious
exacerbations.
The healthy group was randomly selected from
voluntary patient relatives or visitors. And 15capacity in pulmonary function test (PFT) (mean
FEV1 101713% predicted and mean age
6378 years) were evaluated and the results of
two groups were compared.
Study design
In the same afternoon, each subject performed
STST and 6MWT, with an interval of at least 2 h
between each test; the sequence of the tests was
randomized. The pulmonary function by spirometry
and quadriceps femoris (QF) muscle strength by
manual muscle test and quality of life by physical
mobility category of Nottingham Health Proﬁle
Survey (PMC of NHPS) were evaluated.
The protocol of this study was approved by the
local ethic committee. The aim of the study was
fully explained to participants, and all gave oral
informed consent.Outcome measurements
The evaluation of exercise capacity
Sit-to-Stand Test (STST)
The STST was performed with a standard height
(46 cm) chair without arm rests. The subjects held
their arms stationary by putting their hands on
their hips. The test was ﬁrst demonstrated by a
staff and then performed by a subject. Subjects
were asked to complete the sitting and standing
positions as correctly and as fully without using the
arms for support while rising and sitting. When the
subjects were instructed by the command ‘‘Go!’’,
they stand upright and without delay sit down
again, repeating the procedure as many times as
possible in a 1min period at a self-selected speed
which is they felt safe and comfortable until asked
if they wish to stop. It is taken care to be in full
exention motion and approximately 901 ﬂexion
motion on knee joint. The number of completed
repetitions was recorded. The subjects were
permitted to use rest periods to complete 1min.11
6min walking test (6MWT)
We conducted the 6MWTas described by Guyatt and
colleagues. Subjects were instructed to walk from
end to end at the corridor of the hospital which is
40m long at their own pace, while attempting to
cover as much distance as possible in the allotted
6min without supplemental oxygen. A research
assistant timed the walk and recorded the distance
traveled. The research assistant offered verbal
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6MWT, the total distance covered was recorded to
the nearest meter.6,12
Dyspnea severity by the Modiﬁed Borg Scale
(MBS) and heart rate, blood pressure and pulsed
oxygen saturation (SpO2, with Palco 400 model
pulse oxymeter, Palco Labs, Santa Cruz, USA) were
measured before and at the end of tests. Tests were
not done if SpO2 before test was lower than 90% and
test was terminated according to the patients’
exhausts of the fatigue legs and/or the severity of
dyspnea, etc. reasons or the request from the
subjects to stop.Rating of dyspnea
At a single point in time, the severity of dyspnea on
resting and end of the STST and walking test was
evaluated by MBS. The subjects were informed
about use of this scale. The MBS, the Borg scale
rating of perceived exertion has been modiﬁed to
measure symptoms such as breathlessness. A
commonly used format is a 10-point scale with a
nonlinear scaling scheme using descriptive terms to
anchor responses.13Evaluation of the lung function
Pulmonary function tests (PFTs)
Spirometry was performed by an expert using a
Sensormedics Vmax 22 machine (SensorMedics Inc.,
Anaheim, CA, USA) appropriately to the ATS
criteria’s.14 Forced vital capacity (FVC), FEV1 and
FEV1/FVC values had been recorded.The peripheral muscle strength
As a criterion, only the QF muscle strength was
tested with manual muscle test by the use of
Daniels 0–5 Grading System in sitting position.15Quality of life
The health-related quality of life was conducted
with the NHPS. It is reproducible and valid in the
assessment of chronic diseases and has been used
to describe patients with COPD. The NHPS is a self-
administered questionnaire composed of two sec-
tions containing 45 items. The ﬁrst section contains
38 items assessing energy, pain, emotional reac-
tions, sleep, social isolation and physical mobility.
In this study, only the PMC (eight items) was used.
All questions are yes–no questions. The dimension
scores so that the best function was represented by
a score of 0 and the worst function was represented
by a score of 100.16Statistical analysis
All results are presented as mean7SD. Data
comparison among different tests was performed
by means of ANOVA, while comparisons between
baseline and the end of tests and between the
groups were performed by means of the paired
t-test. Changes from baseline were computed for
each test and compared by means of ANOVA. The
correlation between results of STST and 6MWT was
calculated by Pearson’s and Spearman rank corre-
lation coefﬁcient (r). A P-value of less than 0.05
was considered signiﬁcant.Results
There was no signiﬁcant difference between the
patients with COPD and healthy groups regarding
the demographic data (P40.05, Table 1). PFT
values were lower and smoking history was higher
in patients with COPD compared with healthy
subjects (Po0.05, Table 1).
Forty-eight subjects (40 patients with COPD,
eight healthy subjects) had a history of smoking,
but were not smoking currently. The distribution of
smoking history among the COPD and healthy groups
was statistically signiﬁcant (Po0.05, Table 1).
STST result and 6MWT distance were found to be
signiﬁcantly lower in patients with COPD compared
with healthy individuals (Pp0.01). Furthermore,
QF muscle strength was detected to be lower
(Po0.05), and PFC of NHPS value was found to be
higher, so the quality of life was worse in patients
with COPD (P ¼ 0.001, Table 2).
During 6MWT, a signiﬁcant increase in the heart
rate and systolic blood pressure (systolic BP) and a
decrease in pulsed saturation were determined in
the COPD group (Po0.05), while no change during
STST (P40.05). But the severity of dyspnea
signiﬁcantly increased in both the tests (Po0.05,
Table 3).
In healthy group, while no change was observed
in the severity of dyspnea, heart rate and blood
pressure before and after the test during STST
(P40.05), only the heart rate during 6MWT
was found to be signiﬁcantly increased (Po0.05,
Table 3).
When the correlations of STST and 6MWT results
were examined, STST and 6MWT results were
associated with each other in both groups (for
COPD group, r ¼ 0.75, Po0.001, for the healthy
group, r ¼ 0.54, P ¼ 0.04, Table 4, Fig. 1).
No association was found between both tests and
the PFT parameters in both groups (P40.05). The
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Table 1 Baseline patient characteristics.
COPD group (53) Healthy group (15) P
Male/female gender (no) 33/20 4/11 0.16
Age (yr) 71712 (52–85) 62.8077.65 (54–78) 0.07
Height (cm) 167711 (150–180) 162.3379.17 (146–180) 0.70
Weight (kg) 6675 (48–98) 75.93711.41 (58–102) 0.12
BMI (kg/cm2) 2375 2774 0.07
FVC (l/s) 271 371 0.002
FVC (% predicted) 6072 102713 0.00
FEV1 (l/s) 171 371 0.00
FEV1 (% predicted) 4679 (35–64) 101713 0.00
FEV1/FVC 6272 8275 0.00
The rate of smoking %75 %53 0.01
Smoking year (yr) 38714 22711 0.02
Smoking consumption (packet/day) 170 171 0.15
BMI ¼ body mass index; FVC ¼ forced vital capacity; FEV1 ¼ forced expiratory volume in 1 s.
Data are presented as mean7SD unless otherwise indicated.
Table 2 Results of STST and 6MWT, some parameters of COPD and healthy groups.
COPD group Healthy group P
Sit-to-stand repetitions (min1) 1575 (4–23) 2074 (14–25) 0.01
6min walking distance (m) 112761 (20–300) 423760 (320–560) 0.001
The score of PMC of NHPS 4672 276 0.001
Strength of QF muscle, value/5
Left 471 571 0.02
Right 471 571 0.03
PMC of NHPS ¼ physical mobility category of Nottingham health proﬁle survey; QF ¼ quadriceps femoris.
Data are presented as mean7SD.
The Sit-to-Stand Test in patients with COPD 289result of STST showed correlation with the result of
PMC of NHPS and QF muscle strength in healthy
group. In COPD group, STST result was signiﬁcantly
associated with age, dyspnea at rest and effort in
addition to these parameters (Po0.05). 6MWT
result signiﬁcantly correlated with age, PMC of
NHPS result, QF muscle strength, severity of
dyspnea and the last heart rate in patients with
COPD while 6MWT result was found to be associated
with only age and QF muscle strength in healthy
group (Po0.05, Table 4).Discussion
The purpose of this study is to compare the utility
of the STST to that of 6MWT in the evaluation of the
functional status in patients with COPD. In the
literature, STST is generally used to determine the
functional status of elderly patients with orthope-dic diseases.8,9,17–20 The 6MWT is usually used for
patients with COPD. The timed walk distance has
been demonstrated to be a strong predictor of
survival in patients with COPD.1,2,4–6,12,21 There-
fore, we consider that STST could determine the
functional status as the 6MWT in patients with
COPD.
We found that the results of the two tests were
correlated with each other in both the patients
with COPD and the healthy individuals. This
correlation was particularly strong in the COPD
group. We hypothesized that the reason for a lower
correlation coefﬁcient in the healthy group was
probably the limited number of subjects in this
group. Furthermore, we found that similar to
6MWT, the results of STST were correlated with
age and quality of life and severity of dyspnea and
peripheral muscle strength values in patients with
COPD and healthy individuals. This result led us to
an assumption that the two tests are consistent
with one another. As a difference, we demon-
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Table 3 Change of cardiorespiratory parameters during the STST and 6MWT.y
STST 6MWT
COPD Healthy P COPD Healthy P
Dyspnea, Borg index
Baseline 272 0 0.00 371 0 0.00
End 572 0 0.00 772 071 0.00
Change from baseline 271 0 0.00 372 071 0.00
Heart rate (beats/min)
Baseline 8779 79713 0.10 87711 78712 0.05
End 98722 89711 0.10 110720 88712 0.001
Change from baseline 1073 3710 0.07 2178 1077 0.01
Systolic BP (mmHg)
Baseline 14073 13371 0.18 14073 13374 0.16
End 14278 13878 0.22 14872 13878 0.001
Change from baseline 471 372 0.07 974 370 0.001
Diastolic BP (mmHg)
Baseline 7871 7172 0.28 7871 7471 0.32
End 8070 7470 0.08 8071 7471 0.08
Change from baseline 171 272 0.27 272 171 0.24
SpO2 (%)
Baseline 9373 9771 0.00 9373 9871 0.00
End 9274 9771 0.01 8974 9771 0.00
Change from baseline 071 071 0.70 373 071 0.01
Systolic BP ¼ systolic blood pressure; Diastolic BP ¼ diastolic blood pressure; SpO2 ¼ pulsed oxygen saturation.
yData are presented as mean7SD unless otherwise indicated.
Po0.05.
S. Ozalevli et al.290strated that the cardiorespiratory stress after STST
was lower than the response that was obtained
after the 6MWT.
In order to compare the two tests, we tried to
explore the correlation between the results ob-
tained from both tests and main functional para-
meters of the subjects (pulmonary function,
dyspnea, peripheral muscles strength, age, etc.).
It is determined that FEV1 is a poor predictor of
symptoms and disability in COPD patients.1,3,5,22
We did not ﬁnd a correlation between the FEV1 and
functional status (measured by STST and 6MWT) in
patients with COPD and in healthy individuals. Our
results supported that FEV1 is not a strong predictor
of functional status in healthy individuals either. In
the relevant studies, these results about FEV1
underline the importance of performing exercise
evaluation in patients with COPD. Thus, exercise
test must be performed in these patients in order
to assess their disability, because this information
cannot be derived from traditional functional
ﬁndings.2,3,23
Generally, peripheral muscle weakness is a result
of chronic inactivity and muscle deconditioning inpatients with COPD and may play a role in the
reduction of functional capacity.24 Additionally in
these patients, dyspnea and lower limb muscular
weakness may be accompanied by cardiorespira-
tory limitation, which affects the results of
performance.4 It is known that 6MWT determines
the strength of lower extremity muscles.25,26
We found that QF muscle strength (measured
by the manual muscle test and 6MWT) is lower in
COPD patients compared to that of the healthy
individuals.
STST performance is inﬂuenced by some factors
associated with balance and mobility. It is deter-
mined that STST performance is inﬂuenced not only
by lower limbs muscle strength but also multiple
physiological and psychological processes and re-
presents a particular transfer skill.8,17 But, it is
obviously known that quadriceps muscle strength is
extremely important to develop the movement
across the knee that is necessary to enable
functionally limited elders to arise from a
chair.20,27 So, it was concluded that the STST
provided a reasonably reliable and valid indicator
of lower extremity muscle performance in
ARTICLE IN PRESS
Table 4 Relationship between the results of STST and 6MWT and some outcome parameters.
Sit-to-Stand test 6min walking test
COPD r Healthy r COPD r Healthy r
Sit-to-stand repetitions (min1) — — 0.75 0.54
Age (yr) 0.87 0.07 0.65 0.69
BMI (kg/cm2) 0.16 0.20 0.11 0.13
FVC (%) 0.14 0.30 0.13 0.09
FEV1 (%) 0.22 0.35 0.29 0.06
FEV1/FVC 0.18 0.09 0.05 0.10
The score of PMC of NHPS 0.63 0.69 0.55 0.28
Strength of QF muscle
Left 0.65 0.48 0.62 0.42
Right 0.65 0.45 0.60 0.34
Baseline dyspnea, Borg index 0.75 — 0.75 —
End dyspnea, Borg index 0.80 — 0.85 0.28
Baseline heart rate (beats/min) 0.25 0.40 0.33 0.40
End heart rate (beats/min) 0.04 0.38 0.47 0.26
Baseline systolic BP (mmHg) 0.09 0.08 0.02 0.04
End systolic BP (mmHg) 0.06 0.15 0.30 0.03
Baseline SpO2 (%) 0.11 0.06 0.24 0.06
End SpO2 (%) 0.20 0.01 0.24 0.09
r: Pearson’s and Spearman rank correlation coefﬁcient.
BMI ¼ body mass index; FVC ¼ forced vital capacity; FEV1 ¼ forced expiratory volume in 1 s; PMC of NHPS ¼ physical mobility
category of Nottingham health proﬁle survey; QF ¼ quadriceps femoris; Systolic BP ¼ systolic blood pressure; SpO2 ¼ pulsed
oxygen saturation.
0.05XP40.01.
0.01XP40.001.
Pp0.001.
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Figure 1 Relationship between the 6min walking distance and result of STST in healthy and COPD groups.
The Sit-to-Stand Test in patients with COPD 291generally active older adults and renal transplant
candidates.11,19,20 Lord et al.17 indicated that STST
performance is inﬂuenced by quadriceps strength,
which was the most important variable in explain-
ing the result of STST. Lindemann et al.18 showed
that STST was able to measure power duringperformance of a daily task and it might detect
decline in muscle function earlier than measure-
ment of the functional status. It has been esti-
mated that the STST is a practical mean of
documenting lower extremity muscle perfor-
mance.11 We found that STST was related with
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healthy groups although it is not a strength test.
Thus, we concluded that the STST is able to identify
peripheral muscle weakness in patients with COPD.
Age and dyspnea are the strongest and most
consistent correlates of impaired exercise perfor-
mance in patients with chronic airway obstruction.3
It has been reported that perceived breathlessness
is correlated with walking distance in patients with
COPD.2,21,22 But, Torres et al.4 found that 6MWT
provides independent information regarding the
functional status of COPD patients as it does not
correlate with the changes in dyspnea severity and
quality of life. In contrast, Wijkstra et al. found
that the 6MWT is correlated with quality of life and
dyspnea.6,23 We found that, similar to the 6MWT,
STST is correlated with severity of dyspnea, age
and quality of life. These results show that the STST
is sensitive for respiratory symptoms and clinic of
patients with COPD.
Stel et al.2 determined a relationship between
the 6MWTand desaturation and heart rate. In COPD
patients, systolic BP and heart rate and dyspnea
were signiﬁcantly increased and pulsed saturation
was signiﬁcantly decreased at the end of the
6MWT.28 Likewise, in our study, the 6MWT revealed
similar results in COPD patients. Since STST does
not cause an increase in heart rate systolic BP and a
decrease in pulsed saturation as in the 6MWT, its
application is easier and it produces less cardiac
stress. Anyway, it is widely known that standing
from a sitting position is a very common, yet
essential activity in daily life.7 Since STST was
found to be related with result of NHP evaluating
functional independence in daily living activities, it
can deﬁne the independence of the patient in daily
life activities.
Celli et al.29 and Delgado et al.30 showed that the
arm muscles are active during walking exercise in
some patients with COPD and this might be a source
of reﬂex impulses to the respiratory centers,
leading to dis-synchronous breathing and conse-
quently impairing gas exchange. As we compared
the two tests, we hypothesized that upper ex-
tremity muscle activation might be affected by the
motivation and encouragement of the patients by
the researchers. However, in STST, arm activities
are absent in contrast to 6MWT, so arm muscles are
not active as in walking. It should be mentioned
that STST may be a familiar form of exercise for our
patients and may need less ventilatory demand
than the 6MWT. We did not measure breathing
pattern or ventilatory demand during the STST and
6MWT, and further studies are needed.
Similarly, it was found that encouragement
signiﬁcantly increased the distance walked in6MWT.31 The lack of encouragement inﬂuenced
patient response in the STST test. Since this test is
easier than 6MWT, STST can evaluate the exercise
capacity more accurately than 6MWT in patients
with COPD.
In addition, Poulain et al.21 and Schenkel et al.32
determined that daily activities, such as walking,
etc., are associated with transient oxygen desa-
turation in patients with moderate-to-severe
COPD, even without marked resting hypoxemia.
We also found that 6MWT caused desaturation in
patients with COPD. The absence of desaturation in
STST shows that STST can evaluate the exercise
capacity more accurately.
In conclusion, we prove that STST determines the
functional state correctly like 6MWT in patients
with moderate-to severe COPD as STST is compar-
ably less hemodynamically stressful, easier to apply
and more sensitive for the patient’s clinical status
compared to 6MWT. These ﬁndings led us to the
idea of using STST as an alternative of 6MWT to
assess the functional capacity in patients with
moderate-to-severe COPD.References
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